Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hsuan-Jen Shih"'
Autor:
Huai-Chueh Gem Wu, Ling-Jung Chiu, Tung-Liang Lin, Yuen-Chin Ong, Ming-Chung Kuo, Yen-Min Huang, Jin-Hou Wu, Hsuan-Jen Shih, Ning-Chun Chen, Yu-Shin Hung, Hung Chang, Ming-Chung Wang, Hsiao-Wen Kao
Publikováno v:
HemaSphere, Vol 7, p e13238b4 (2023)
Externí odkaz:
https://doaj.org/article/c100bec998db40dbb3341e6bb73f93c7
Autor:
Yi-Ru Pan, Chiao-En Wu, Ming-Huang Chen, Wen-Kuan Huang, Hsuan-Jen Shih, Keng-Li Lan, Chun-Nan Yeh
Publikováno v:
Vaccines, Vol 8, Iss 4, p 703 (2020)
Cholangiocarcinoma (CCA) is a malignant tumor with aggressive biological behavior. Immune checkpoints such as cytotoxic T-lymphocyte antigen 4 (CTLA4) and antiprogrammed death 1 (PD-1) are critical immune-checkpoint molecules that repress T-cell acti
Externí odkaz:
https://doaj.org/article/a910183474874ec79905d2e3704a40f1
Autor:
Ning-Chun Chen, Hung Chang, Hsiao-Wen Kao, Che-Wei Ou, Ming-Chung Kuo, Po-Nan Wang, Tung-Liang Lin, Jin-Hou Wu, Yu-Shin Hung, Yi-Jiun Su, Yuen-Chin Ong, Hsuan-Jen Shih
Publikováno v:
Clinical and Experimental Medicine.
Autor:
Yen-Min Huang, Hsuan-Jen Shih, Yi-Chan Chen, Tsan-Yu Hsieh, Che-Wei Ou, Po-Hsu Su, Shih-Ming Chen, Yun-Cong Zheng, Li-Sung Hsu
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 1985
Background: Pancreatic cancer can induce a hypercoagulable state which may lead to clinically apparent thrombosis. However, the effect of anticoagulants remains ambiguous. This study aimed to investigate the potential effect of long-term systemic ant
Publikováno v:
International Journal of Molecular Sciences. 24:602
Epidermal growth factor receptor (EGFR) triple mutations with exon 19 deletion (del19), T790M, and cis-C797S (del19/T790M/cis-C797S mutations) frequently occur in patients with non-small cell lung cancer (NSCLC), while progression to frontline EGFR-t
Autor:
Ming Huang Chen, Hsuan Jen Shih, Chiao-En Wu, Yi Ru Pan, Wen-Kuan Huang, Keng Li Lan, Chun Nan Yeh
Publikováno v:
Vaccines
Vaccines, Vol 8, Iss 703, p 703 (2020)
Volume 8
Issue 4
Vaccines, Vol 8, Iss 703, p 703 (2020)
Volume 8
Issue 4
Cholangiocarcinoma (CCA) is a malignant tumor with aggressive biological behavior. Immune checkpoints such as cytotoxic T-lymphocyte antigen 4 (CTLA4) and antiprogrammed death 1 (PD-1) are critical immune-checkpoint molecules that repress T-cell acti
Autor:
Tung‑Liang Lin, Jin‑Hou Wu, Yen Min Huang, Po‑Nan Wang, Yu‑Shin Hung, Lee‑Yung Shih, Tzung‑Chih Tang, Hsiao‑Wen Kao, Po Dunn, Ming‑Chung Kuo, Hsuan‑Jen Shih, Hung Chang
Publikováno v:
Oncology Letters
The diagnosis of chronic lymphocytic leukemia (CLL) presenting with ascites is predominantly based on the morphological and immunophenotypic characteristics, which are comparable to peripheral blood and bone marrow cells. However, it is relatively di
Autor:
Mark McHale, Li-Tzong Chen, Wei-Ling Chang, Jin Hyun Park, Chih-Yi Hsieh, Nicola McIntyre, Hsuan-Jen Shih, Wei Peng Yong, Ji Won Kim, Alex Y. Chang, Bertil Lindmark, Do-Youn Oh, Ying-Chen Chen
Publikováno v:
HepatoBiliary Surgery and Nutrition. 8:AB063-AB063
BACKGROUND: Biliary tract cancer (BTC) is a rapidly progressing cancer with limited response to chemotherapy. First line therapy (gem/cis) was defined in the ABC-02 study (Valle et al.), where a 26% response was seen. HER family receptors are overexp
Autor:
Bertil Lindmark, Ji Won Kim, Mark McHale, Li-Tzong Chen, Wei-Ling Chang, Alex Y. Chang, Chih-Yi Hsieh, Jin Hyun Park, Nicola McIntyre, Do-Youn Oh, Hsuan-Jen Shih, Wei Peng Yong, Ying-Chen Chen
Publikováno v:
Journal of Clinical Oncology. 37:319-319
319 Background: BTC is a rapidly progressing cancer with limited response to chemotherapy. First line therapy (gem/cis) was defined in the ABC-02 study (Valle et al), where a 26% response was seen. HER family receptors are overexpressed and may be in
Autor:
Po-Nan Wang, Lee-Yung Shih, Po Dunn, Hung Chang, Ming-Chung Kuo, Yu-Shin Hung, Jin-Hou Wu, Hsuan-Jen Shih
Publikováno v:
Acta Haematologica. 131:187-192
Testicular lymphoma is a rare condition, so large scale prospective studies are difficult to conduct. Consensus regarding standard treatment is lacking. This study retrospectively reviewed 22 patients with testicular lymphoma. One patient with diffus